Atlas Trials

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

Clinical trial NCT04373460 · COMPLETED

Trial details

NCT number
NCT04373460
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SARS-CoV 2
Start date
2020-06-03
Primary completion
2022-01-14
Enrollment
1225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.